Relapsing fever borreliosis in interleukin-10-deficient mice.
Relapsing fever (RF) is a spirochetal infection characterized by periods of sickness with fever at time of high bacteremia that alternate with afebrile periods of relative well being during low bacteremia. Patients with epidemic RF who are doing relatively well have extraordinarily high levels of interleukin-10 (IL-10) in the circulation. We investigated the possibility that IL-10 plays an important protective role in this infection using wild-type and IL-10-deficient mice inoculated with virulent serotype 2 of the RF spirochete Borrelia turicatae. During peak bacteremia there was increased systemic production of IL-10 that quickly resolved in the postpeak period; in contrast, IL-6 and CXCL13 production increased during the peak but remained elevated during postpeak bacteremia. IL-10 deficiency resulted in lower bacteremia, increased specific antibody production, higher production of CXCL13 and IL-6, and thrombotic and hemorrhagic complications affecting multiple organs with secondary tissue injury. Our results revealed that production of IL-10 is highly regulated during RF and plays an important protective role in the prevention of hemorrhagic and thrombotic complications at the cost of reduced pathogen control.
Londoño
Diana
D
Department of Neurology and Neuroscience and Center for Emerging Pathogens at UMDNJ-New Jersey Medical School, Newark, New Jersey 07103, USA.
Marques
Adriana
A
Hornung
Ronald L
RL
Cadavid
Diego
D
D000818:Animals; D000907:Antibodies, Bacterial / Q000097:blood; D016470:Bacteremia / Q000276:immunology; D054382:Chemokine CXCL13 / Q000276:immunology / Q000378:metabolism; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D016753:Interleukin-10 / Q000172:deficiency* / Q000276:immunology*; D015850:Interleukin-6 / Q000276:immunology / Q000378:metabolism; D051379:Mice; D016133:Polymerase Chain Reaction; D012061:Relapsing Fever / Q000097:blood / Q000276:immunology* / Q000473:pathology*
D000907:Antibodies, Bacterial; D054382:Chemokine CXCL13; D015850:Interleukin-6; D016753:Interleukin-10
Infect Immun. 2001 May;69(5):3389-97
11292762
Infect Immun. 1997 Aug;65(8):3352-60
9234797
Infect Immun. 2006 Dec;74(12):6750-60
17030581
J Immunol. 2001 Sep 15;167(6):3029-32
11544285
J Neuropathol Exp Neurol. 2007 Mar;66(3):208-17
17356382
J Neuropathol Exp Neurol. 2008 Oct;67(10):976-83
18800010
Clin Infect Dis. 1998 Jan;26(1):151-64
9455525
Infect Immun. 1999 Sep;67(9):4637-45
10456910
J Immunol. 1997 Apr 1;158(7):3311-6
9120288
Microbiol Rev. 1986 Dec;50(4):381-400
3540570
J Immunol. 2003 Apr 1;170(7):3819-27
12646649
Lab Invest. 2004 Feb;84(2):160-72
14688796
Cell Microbiol. 2000 Dec;2(6):591-9
11207611
J Immunol. 2006 Nov 15;177(10):7076-85
17082624
J Immunol. 2008 Aug 1;181(3):2076-83
18641346
J Infect Dis. 2000 Jan;181(1):203-9
10608768
Infect Immun. 2005 Nov;73(11):7669-76
16239571
Hepatology. 1995 May;21(5):1465-8
7737654
J Leukoc Biol. 2002 Sep;72(3):503-11
12223518
Wien Klin Wochenschr. 2006 Nov;118(21-22):653-8
17160603
Immunobiology. 1993 Nov;189(3-4):316-39
8125515
Trans R Soc Trop Med Hyg. 1977;71(1):43-8
871032
Infect Immun. 1999 Oct;67(10):5142-50
10496888
J Exp Med. 1993 Apr 1;177(4):1205-8
8459215
J Immunol. 2005 May 1;174(9):5681-6
15843569
J Exp Med. 1994 Feb 1;179(2):631-42
8294872
J Infect Dis. 1993 Jul;168(1):143-51
8515101
Am J Pathol. 2007 Jan;170(1):251-62
17200198
Infect Immun. 2006 Nov;74(11):6408-18
16940140
Infect Immun. 1984 Sep;45(3):572-6
6332075
Mol Microbiol. 1999 Dec;34(5):1120-32
10594835
Infect Immun. 1995 Nov;63(11):4439-47
7591083
Infect Immun. 1996 Aug;64(8):3180-7
8757851
J Clin Invest. 1990 May;85(5):1637-47
2332509
Infect Immun. 2003 Dec;71(12):7087-98
14638799